Image

School Evaluation and Supports of Children with Pelizaeus-Merzbacher disease

Study on Educational Support for Children with a Rare Genetic Disorder

Recruiting
3-25 years
All

This study investigates how schools address the needs of children with Pelizaeus-Merzbacher disease, a rare genetic disorder affecting the nervous system. The purpose is to understand the support provided in school settings to accommodate learning needs. Pelizaeus-Merzbacher disease can cause problems with movement, coordination, and learning abilities.

Participants will share information about their educational experiences, including any psychoeducational testing and Individualized Education Programs (IEPs). The study will gather data on how schools implement strategies and resources to support students with this condition, focusing on public or public charter schools.

  • Who can participate: Children, adolescents, and young adults aged 3 to 25 years with a genetic diagnosis of Pelizaeus-Merzbacher disease can participate. Participants must be involved with the national PMD Family Support group and served by a public school or public charter school. Exclusion criteria include individuals outside the specified age range and those not enrolled in the specified educational settings.
  • Study details: Participants will be asked to provide information about their educational experiences, including psychoeducational testing and IEPs if available. This information will help to understand how schools support learning needs for those with Pelizaeus-Merzbacher disease.
Study details
    Pelizaeus-Merzbacher disease

TX10559

19 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.